SUBSCRIBE
SUBSCRIBE

Cassava Sciences Inc.

NEWS
Deals
Top 2003 Stories From The BioSpace NewsBeat
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Lone Star Bio
New Publication Highlights Basic Science Supporting Simufilam
June 12, 2023
 · 
5 min read
Lone Star Bio
Cassava Sciences to Present at the 2023 Jefferies Global Healthcare Conference
June 1, 2023
 · 
2 min read
Lone Star Bio
Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease
May 11, 2023
 · 
5 min read
Lone Star Bio
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
May 8, 2023
 · 
7 min read
Business
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
May 1, 2023
 · 
9 min read
Lone Star Bio
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
April 26, 2023
 · 
1 min read
Business
Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates
February 28, 2023
 · 
10 min read
Drug Development
Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s Disease
February 8, 2023
 · 
5 min read
Drug Development
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
January 24, 2023
 · 
11 min read
Business
Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MD
December 20, 2022
 · 
1 min read
Load More